SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Indo Us Bio-Tech informs about outcome of board meeting

07 Jul 2023 Evaluate
Indo Us Bio-Tech has informed that the meeting of the board of directors of the company was held on Friday, July 7, 2023 at 04:00 PM and concluded on 04:30 PM at the registered office of the company situated at 309, Shanti Mall, Satadhar Char Rasta, Opp. Navrang Tower, Sola Road, Ahmedabad, Gujarat, 380061. The board considered and approved following;  Increase in Authorised Share Capital of the Company from Rs. 11,00,00,000 (Eleven Crores only), divided into 1,10,00,000 Equity Shares of Re. 10 (Rupee Ten Only) each to Rs. 21.00,00,000 (Twenty onc Crores only), divided into 2,10,00,000 Equity Shares of Re. 10 (Rupee Ten Only) each and consequent change in Capital Clause of Memorandum of Association of the Company; The Board recommended the Bonus Issue of Equity Shares in the proportion of 1 (One) Equity Share of Rs, 10 each for every 1 (one) Equity Shares of Re 10 each held by the shareholders of the Company as on the record date; Considered and approved Notice of Postal Ballot subject to the approval of the shareholders of the Company and applicable regulatory authorities; The appointment of CS Amrish Gandhi (Membership No. F8193), Proprietor of M/S Amrish Gandhi & Associates as a matters. Scrutinizer for conducting Postal Ballot and E-Voting Process in fair and transparent manner for the above subject Regulations.) The detailed disclosure as required under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements 2015 read with SEBI Circular No. CIR/CFD/CMD/4/2015 Annexure-I.

The above information is a part of company’s filings submitted to BSE.

Indo US Bio-Tech Share Price

108.00 -1.43 (-1.31%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Venkys India 1589.25
Mangalam Global Ent 12.93
Kaveri Seed 924.50
Regaal Resources 85.04
Simran Farms 165.70
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×